PubRank
Search
About
Alexandre Louvet
Author PubWeight™ 36.84
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Early liver transplantation for severe alcoholic hepatitis.
N Engl J Med
2011
8.50
2
M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.
Hepatology
2013
2.16
3
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach.
Hepatology
2014
2.05
4
Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.
JAMA
2013
1.94
5
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data.
Gut
2010
1.83
6
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration.
Hepatology
2010
1.82
7
Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
J Hepatol
2011
1.73
8
Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
Gastroenterology
2009
1.67
9
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis.
PLoS One
2009
1.25
10
Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis.
Glycobiology
2005
1.13
11
The evolution of severe steatosis after bariatric surgery is related to insulin resistance.
Gastroenterology
2006
1.09
12
Comment on: "Management of alcohol dependence in patients with liver disease".
CNS Drugs
2013
1.07
13
NOD2: a potential target for regulating liver injury.
Lab Invest
2008
0.95
14
Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control.
Gastroenterology
2009
0.92
15
Evaluation of amantadine in chronic hepatitis C: a meta-analysis.
J Hepatol
2004
0.91
16
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.
Eur J Gastroenterol Hepatol
2011
0.89
17
Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease.
Inflamm Bowel Dis
2009
0.86
18
Peroxisome proliferator-activated receptors in HBV-related infection.
PPAR Res
2009
0.82
19
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.
Liver Transpl
2007
0.81
20
Treatment of severe forms of alcoholic hepatitis: where are we going?
J Gastroenterol Hepatol
2008
0.80
21
Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients.
Proteomics Clin Appl
2010
0.80
22
Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France.
Hepatology
2009
0.79
23
Drug-Eluting Beads Loaded With Doxorubicin (DEBDOX) Chemoembolisation Before Liver Transplantation for Hepatocellular Carcinoma: An Imaging/Histologic Correlation Study.
Cardiovasc Intervent Radiol
2014
0.77
24
Liver fibrogenesis and genetic factors.
Clin Res Hepatol Gastroenterol
2011
0.77
25
Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France.
J Hepatol
2008
0.76
26
Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.
J Clin Gastroenterol
2017
0.75
27
Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin.
J Hepatol
2011
0.75
28
[Therapeutic misadventure with acetaminophen in alcoholics].
Presse Med
2008
0.75
29
Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.
J Clin Gastroenterol
2017
0.75
30
[Acute recurrent pancreatitis in a composite CFTR heterozygote and Spink1 heterozygote patient].
Gastroenterol Clin Biol
2006
0.75